Sat, Aug 2, 2014, 5:24 AM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Nxstage Medical, Inc. Message Board

  • thor1294 thor1294 Oct 5, 2011 4:14 AM Flag

    chart reflection

    small bounce back on market. I watch S&P chart, we came close to 10,500 area which I consider dire straits. NXTM hanging tough, needs to develop handle another few days. If we can get through this rough patch NXTM may take off going into Nov.earnings report.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • vincent.amato@ymail.com vincent.amato Oct 12, 2011 4:10 PM Flag

      The problem with this stock is not the product is the debt that they carry vs revenue. They are still not profitable and with global expansion in place it may 2 to 3 years to become a profitable company and there is a cost to expansion. However if willing to wait this stock is a $45 - $50 in 2 to 3 years. However I would sit back for now and wait for the price to go back down to 17 -18 range and jump in and forget about the stock

      • 1 Reply to vincent.amato
      • yes, debt seems to be problem. However, each quarter it appears to be dropping. This quarter I expect to see revenues up a little more and debt down a little more. Once in a blue moon I'll check the headlines on FMS board to keep track on what's happening in that area. Found this article which maybe of interest. Accoring to the U.S. Renal Data system 400,000 americans were receiving regular dialysis at the end of 2009. Health experts expect that to double in 10 years. That's sad, but a fact of life. As you can see this part of health care is a huge market and NXTM has a chance to be a front runner with there portable diaylsis machines. Your projections of 2 to 3 years down the line could be spot on. Good hunting

 
NXTM
13.12-0.23(-1.72%)Aug 1 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.